Briagen Observational Study
NCT04090970 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2019-12-17
Summary
This research study is evaluating a study product called Briagen™ as a possible treatment for wound healing after Mohs procedure.
Conditions
- Mohs Surgery
Interventions
- DEVICE
-
Briagen
Natural complex carbohydrate wound dressing for skin wounds
Sponsors & Collaborators
-
Gemstone Biotherapeutics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-26
- Primary Completion
- 2020-03-31
- Completion
- 2020-05-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers
NCT02563522 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
NCT02554851 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities
NCT00493051 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
NCT01070433 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
NCT05930210 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds
NCT02028923 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
NCT00658957 ·Status: TERMINATED ·Phase: PHASE2
-
Mirragen Diabetic Foot Ulcer Study
NCT06598241 ·Status: RECRUITING
-
Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue
NCT02632929 ·Status: COMPLETED
-
BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
NCT00434538 ·Status: TERMINATED ·Phase: PHASE3
-
A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC
NCT06511596 ·Status: COMPLETED ·Phase: NA
-
Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers
NCT00512538 ·Status: TERMINATED ·Phase: PHASE3
-
The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial
NCT01228500 ·Status: WITHDRAWN ·Phase: NA
-
Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM
NCT06565156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers
NCT05099367 ·Status: RECRUITING ·Phase: NA
-
A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers
NCT02799121 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
NCT00761176 ·Status: TERMINATED ·Phase: NA
-
Clinical and Mechanistic Demonstration of a Bioelectric Dressing System for Non-healing Wound Management: A Phase II Trial
NCT01784887 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Assessment of the Wound Healing Efficacy and Tolerance of a Medical Device on Wounds in Healthy Subjects.
NCT04687839 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
NCT01629199 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers
NCT06999590 ·Status: RECRUITING ·Phase: PHASE4
-
Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People
NCT05251480 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
NCT00351767 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
NCT00069446 ·Status: COMPLETED ·Phase: PHASE1
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
NCT04920253 ·Status: RECRUITING ·Phase: NA